These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 30031696)

  • 1. Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk.
    Strand MA; Eukel H; Burck S
    Res Social Adm Pharm; 2019 Aug; 15(8):1032-1036. PubMed ID: 30031696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist utilization of prescription opioid misuse interventions: Acceptability among pharmacists and patients.
    Riley TB; Alemagno S
    Res Social Adm Pharm; 2019 Aug; 15(8):986-991. PubMed ID: 30665825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
    Nielsen S; Kowalski M; Wood P; Larney S; Bruno R; Shanahan M; Lenton S; Dietze P; Green T; Murnion B; Ritter A
    Res Social Adm Pharm; 2019 Aug; 15(8):1047-1055. PubMed ID: 30396825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An opioid dispensing and misuse prevention algorithm for community pharmacy practice.
    Rickles NM; Huang AL; Gunther MB; Chan WJ
    Res Social Adm Pharm; 2019 Aug; 15(8):959-965. PubMed ID: 29525483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
    Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
    Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose.
    Skoy E; Eukel H; Werremeyer A; Strand M; Frenzel O; Steig J
    J Am Pharm Assoc (2003); 2020; 60(1):117-121. PubMed ID: 31677933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the theory of planned behavior to investigate community pharmacists' beliefs regarding engaging patients about prescription drug misuse.
    Fleming ML; Bapat SS; Varisco TJ
    Res Social Adm Pharm; 2019 Aug; 15(8):992-999. PubMed ID: 30442574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
    Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
    Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges faced with opioid prescriptions in the community setting - Australian pharmacists' perspectives.
    Makdessi CJ; Day C; Chaar BB
    Res Social Adm Pharm; 2019 Aug; 15(8):966-973. PubMed ID: 30819418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment.
    Norwood CW; Wright ER
    Res Social Adm Pharm; 2016; 12(2):257-66. PubMed ID: 26143489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.
    Charron E; Brooks JH; Peterson KT; Akinwolere OG; Winhusen T; Cochran G
    Res Social Adm Pharm; 2023 Aug; 19(8):1171-1177. PubMed ID: 37142474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the RESPOND Toolkit on community pharmacists' opioid safety attitudes, self-efficacy, and knowledge.
    Irwin AN; Novak K; Alley L; Havlin T; O'Kane N; Johnston K; Hildebran C; Carson J; Hartung DM
    J Am Pharm Assoc (2003); 2020; 60(3):450-455.e3. PubMed ID: 31919007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Pharmacists' Perceptions After a Training in Opioid Misuse and Accidental Overdose Prevention.
    Eukel HN; Skoy E; Werremeyer A; Burck S; Strand M
    J Contin Educ Health Prof; 2019; 39(1):7-12. PubMed ID: 30614959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Experimental Test of the Effectiveness of Unsolicited Reporting by a Prescription Drug Monitoring Program in Reducing Inappropriate Acquisition of Opioids.
    McDonald DC; Carlson KE; Jalbert SK
    Pain Med; 2019 May; 20(5):944-954. PubMed ID: 29868715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid risk screening: Program evaluation from the community pharmacists' perspective.
    Frenzel O; Eukel H; Lothspeich E; Skoy E; Steig J; Strand M; Werremeyer A
    J Am Pharm Assoc (2003); 2022; 62(3):859-863.e1. PubMed ID: 34953730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and Misuse of Opioids in Maine: Results From Pharmacists, the Prescription Monitoring, and the Diversion Alert Programs.
    Piper BJ; Desrosiers CE; Lipovsky JW; Rodney MA; Baker RP; McCall KL; Nichols SD; Martin SL
    J Stud Alcohol Drugs; 2016 Jul; 77(4):556-65. PubMed ID: 27340958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists Who Screen and Discuss Opioid Misuse With Patients: Future Directions for Research and Practice.
    Cochran G; Field C; Lawson K
    J Pharm Pract; 2015 Aug; 28(4):404-12. PubMed ID: 24532819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.